---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-002612"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2023-02-13T23:59:59+00:00"
generated_at: "2026-06-19T15:54:31.113277+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q4 revenue $32M (+14% YoY); COO Vazquez retiring Apr 3

## Summary
- Q4 revenue $32.0M (+14% YoY); full-year revenue $115.4M (+12.4% YoY).
- GAAP gross margin 16.5% (17.1% non-GAAP); operating loss $45.1M.
- Tablo installed base grew 54% YoY to ~4,000 systems; 800 home units.
- FY 2023 guidance reaffirmed: revenue $140-150M, non-GAAP gross margin ~20%.
- COO Martin Vazquez retiring Apr 3, 2023; expected 6-month consulting arrangement.

## SEC filing metadata
- accession: 0000950170-23-002612
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2023-02-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017023002612/0000950170-23-002612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017023002612/om-20230213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-002612
- JSON: https://secwatch.observer/filing/0000950170-23-002612.json
- Plain text: https://secwatch.observer/filing/0000950170-23-002612.txt

## Key facts
- Earnings Releases
  Outset Medical, Inc. reported the fourth quarter and full year ended December 31, 2022 results: revenue Revenue for the fourth quarter of 2022 was $32.0 million, net income Net loss was ($41.4) million. Guidance reaffirmed.
  - Period: the fourth quarter and full year ended December 31, 2022
  - Revenue: Revenue for the fourth quarter of 2022 was $32.0 million
  - Net income: Net loss was ($41.4) million
  - Guidance: reaffirmed
  - Result: reported results
  source text: Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017023002612/0000950170-23-002612-index.htm
- Executive change
  Martin Vazquez departed as Chief Operating Officer at Outset Medical, Inc..
  - Action: retire
  - Role: Chief Operating Officer
  source text: On February 13, 2023, Martin Vazquez informed the Company of his decision to retire from his role as Chief Operating Officer of the Company effective April 3, 2023 to pursue personal opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017023002612/0000950170-23-002612-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.